Component Analysis for Motivational Interviewing

NCT01642381 | Completed DMC

• 1 other identifier: AA 020077-01A1
• Study Type: interventional
• Target: 139
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to investigate the critical components of motivational interviewing (MI), a psychotherapeutic intervention, in reducing heavy or problematic drinking. The study will disaggregate MI into its component parts and test full MI compared to MI without its directive strategies. This study will test whether the directive elements of MI are critical or whether MI effects may be attributable solely to its Rogerian, non-directive components. For more information, go to http://caspirnyc.org/p\_motion.html

Conditions

Alcohol-Related Disorders; Alcohol Use Disorders; Alcohol Drinking; Alcoholism; Alcohol Abuse

Keywords

Drinking; Alcohol Problems; Alcoholism; Moderation-Oriented Treatment; Controlled Drinking; Reduced Drinking; Heavy Drinking; Problematic Drinking; Non-Abstinence-based Drinking

Outcome Measures

Primary Outcomes (1)

• Time Line Follow Back

  Calendar-based method of recording drinking patterns. Data will be aggregated into summary variables including sum of standard drinks, mean drinks per drinking day, and percent days heavy drinking at multiple time points.

  36 weeks

Study Arms (2)

Psychotherapy

ACTIVE COMPARATOR

Behavioral: Full Motivational Interviewing ("FMI"); Behavioral: Spirit Only Motivational Interviewing ("SOMI")

Self-Change Control ("SCC")

NO INTERVENTION

SCC participants will be told that they should attempt to reduce their drinking over the course of 8 weeks. (If unsuccessful, they will be offered Full Motivational Interviewing therapy sessions.)

Interventions

Full Motivational Interviewing ("FMI") BEHAVIORAL

Relational and technical technical (directive) strategies in counselling sessions to significantly increase commitment strength to reduce drinking.

Psychotherapy

Spirit Only Motivational Interviewing ("SOMI") BEHAVIORAL

Empathic and non-directive counselling based on Rogerian psychotherapy model.

Psychotherapy

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Primary current diagnosis of Alcohol Use Disorder
• Meets DSM-IV criteria for inability to control or cut down on drinking
• Have an average weekly consumption of \>24 standard drinks for men and \>15 standard drinks for women
• Show no evidence of significant cognitive impairment
• Are willing to reduce drinking to non-hazardous levels
• Not seeking to quit drinking
• Agree not to seek additional substance abuse treatment during treatment period
• Fluent in English

You may not qualify if:

• Have a current DSM-IV diagnosis of drug dependence (other than nicotine/marijuana)
• Have a serious psychiatric illness (e.g., psychotic disorder, bipolar disorder, major depression) or substantial suicide or violence risk
• Have clinically severe alcoholism as evidenced by a history of significant medical problems associated with drinking, seizures or severe withdrawal symptoms, or an inpatient treatment episode for drinking
• Legally mandated to receive substance abuse treatment
• Sufficiently socially unstable as to preclude completion of study requirements (e.g., homeless)

Sponsors & Collaborators

• Northwell Health: lead
• National Institute on Alcohol Abuse and Alcoholism (NIAAA): collaborator

Study Sites (1)

North Shore LIJ Health Systems

Great Neck, New York, 11021, United States

Location

MeSH Terms

Conditions

Alcohol-Related Disorders; Alcoholism; Alcohol Drinking

Interventions

Receptor-Like Protein Tyrosine Phosphatases, Class 2

Condition Hierarchy (Ancestors)

Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders; Drinking Behavior; Behavior

Intervention Hierarchy (Ancestors)

Receptor-Like Protein Tyrosine Phosphatases; Protein Tyrosine Phosphatases; Phosphoric Monoester Hydrolases; Esterases; Hydrolases; Enzymes; Enzymes and Coenzymes; Intracellular Signaling Peptides and Proteins; Proteins; Amino Acids, Peptides, and Proteins

Study Officials

• Jonathan Morgenstern, PhD

  North Shore LIJ Health Systems

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 13, 2012
• First Posted: July 17, 2012
• Study Start: May 1, 2012
• Primary Completion: April 1, 2016
• Study Completion: August 1, 2016
• Last Updated: September 12, 2016

Record last verified: 2016-09

Locations

US (1)